| Autor: |
Neĭmark AI, Isaenko VI, Iakovets IaV, Simashkevich AV, Aliev RT |
| Jazyk: |
ruština |
| Zdroj: |
Urologiia (Moscow, Russia : 1999) [Urologiia] 2009 May-Jun (3), pp. 67-70. |
| Abstrakt: |
Our studies of afala in patients with prostatic adenoma demonstrate that afala reduces irritative disorders of urination. Effect of this drug is seen in 98.3% patients during 4 weeks of its use. In longer intake the effect becomes stronger. The dose of 6 tablets a day significantly improves life quality. Three times a day dose is more effective in elimination of nicturia, enhances urine flow rate. Thus, choice of afala dose depends on the symptoms. Afala is indicated for prophylaxis in patients with initial stage of prostatic adenoma and as an alternative to expectation policy. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
